Header Logo

Anita L Ray

TitleFellow,Postdoctoral Research
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentStephenson Cancer Center
AddressORB 344
1122 NE 13th St
Oklahoma City OK 73117
Phone405/271-8001
Fax0
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Saunders AS, Bender DE, Ray AL, Wu X, Morris KT. Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data. PLoS One. 2021; 16(2):e0247233. PMID: 33606788.
      Citations:    Fields:    
    2. Ray AL, Nofchissey RA, Khan MA, Reidy MA, Lerner MR, Wu X, Guo S, Hill SL, Weygant N, Adams SF, Castillo EF, Berry WL, Stout MB, Morris KT. The role of sex in the innate and adaptive immune environment of metastatic colorectal cancer. Br J Cancer. 2020 08; 123(4):624-632. PMID: 32451467.
      Citations:    Fields:    Translation:HumansAnimalsCells
    3. Phinney BB, Ray AL, Peretti AS, Jerman SJ, Grim C, Pinchuk IV, Beswick EJ. MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth. Front Immunol. 2018; 9:1857. PMID: 30298062.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    4. Ray AL, Berggren KL, Restrepo Cruz S, Gan GN, Beswick EJ. Inhibition of MK2 suppresses IL-1ß, IL-6, and TNF-a-dependent colorectal cancer growth. Int J Cancer. 2018 04 15; 142(8):1702-1711. PMID: 29197088.
      Citations: 14     Fields:    Translation:AnimalsCells
    5. Castillo EF, Ray AL, Beswick EJ. MK2: an unrecognized regulator of tumor promoting macrophages in colorectal cancer? Macrophage (Houst). 2016; 3. PMID: 26998523.
      Citations:    
    6. Morris KT, Castillo EF, Ray AL, Weston LL, Nofchissey RA, Hanson JA, Samedi VG, Pinchuk IV, Hudson LG, Beswick EJ. Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses. Oncotarget. 2015 Sep 08; 6(26):22338-47. PMID: 26061815.
      Citations: 12     Fields:    Translation:AnimalsCells
    7. Ray AL, Castillo EF, Morris KT, Nofchissey RA, Weston LL, Samedi VG, Hanson JA, Gaestel M, Pinchuk IV, Beswick EJ. Blockade of MK2 is protective in inflammation-associated colorectal cancer development. Int J Cancer. 2016 Feb 01; 138(3):770-5. PMID: 26238259.
      Citations: 14     Fields:    Translation:AnimalsCells
    Ray's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (42)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _